Advertisement

Thermolabile polymorphism of carnitine palmitoyltransferase 2: A genetic risk factor of overall acute encephalopathy

      Abstract

      Objectives

      Acute encephalopathy is an acute brain dysfunction after preceding infection, consisting of multiple syndromes. Some syndromes, such as acute encephalopathy with biphasic seizures and late reduced diffusion (AESD), are severe with poor outcome, whereas others, such as clinically mild encephalitis/encephalopathy with reversible splenial lesion (MERS), are mild with favorable outcome. Previous study reported the association of the thermolabile polymorphism in Carnitine Palmitoyltransferase 2 (CPT2) gene and severe syndromes of acute encephalopathy. To further explore the pathogenetic role of CPT2 in acute encephalopathy, we conducted a case-control association study of a typical thermolabile CPT2 polymorphism, rs2229291, in 416 patients of acute encephalopathy, including both severe and mild syndromes.

      Methods

      The case cohort consisted of 416 patients, including AESD, MERS, and other syndromes. The control subjects were 100 healthy Japanese. rs2229291 was genotyped by Sanger sequencing. Genetic distribution was compared between the patients and controls using Cochran-Armitage trend test.

      Results

      Minor allele frequency of rs2229291 was significantly higher in AESD (p = 0.044), MERS (p = 0.015) and entire acute encephalopathy (p = 0.044) compared to the controls. The polymorphism showed no significant association with influenza virus, or with outcome.

      Conclusions

      This study provided evidence that CPT2 is a susceptibility gene for overall acute encephalopathy, including both severe and mild syndromes, and suggested that impairment of mitochondrial metabolism is common to various syndromes of acute encephalopathy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mizuguchi M.
        • Yamanouchi H.
        • Ichiyama T.
        • Shiomi M.
        Acute encephalopathy associated with influenza and other viral infections.
        Acta Neurol Scand. 2007; 115: 45-56
        • Hoshino A.
        • Saitoh M.
        • Oka A.
        • Okumura A.
        • Kubota M.
        • Saito Y.
        • et al.
        Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.
        Brain Dev. 2012; 34: 337-343
        • Joshi P.R.
        • Deschauer M.
        • Zierz S.
        Carnitine palmitoyltransferase II (CPT II) deficiency: Genotype-Phenotype analysis of 50 patients.
        J Neurol Sci. 2014; 338: 107-111
        • Chen Y.
        • Mizuguchi H.
        • Yao D.
        • Ide M.
        • Kuroda Y.
        • Shigematsu Y.
        • et al.
        Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy.
        FEBS Lett. 2005; 579: 2040-2044
        • Yao D.
        • Mizuguchi H.
        • Yamaguchi M.
        • Yamada H.
        • Chida J.
        • Shikata K.
        • et al.
        Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy.
        Hum Mutat. 2008; 29: 718-727
        • Kubota M.
        • Chida J.
        • Hoshino H.
        • Ozawa H.
        • Koide A.
        • Kashii H.
        • et al.
        Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children.
        Brain Dev. 2012; 34: 20-27
        • Shinohara M.
        • Saitoh M.
        • Takanashi J.
        • Yamanouchi H.
        • Kubota M.
        • Goto T.
        • et al.
        Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases.
        Brain Dev. 2011; 33: 512-517
        • Saitoh M.
        • Kobayashi K.
        • Ohmori I.
        • Tanaka Y.
        • Tanaka K.
        • Inoue T.
        • Horino A.
        • et al.
        Cytokine-related and sodium channel polymorphism as candidate predisposing factors for childhood encephalopathy FIRES/AERRPS.
        J Neurol Sci. 2016; 368: 272-276
      1. Team RDC, R Development Core Team R. R: A language and environment for statistical computing. R Found Stat Comput 2016;1:409.

      2. Tomas A, Aragon J, Fay MP, Wollschlaeger D, Omidpanah A. Package ‘ epitools ’ R package version 0.5-10. https://CRAN.R-project.org/ 2017.

        • Hoshino A.
        • Saitoh M.
        • Miyagawa T.
        • Kubota M.
        • Takanashi J.
        • Miyamoto A.
        • et al.
        Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy.
        Genes Immun. 2016; 17: 367-369
        • Neilson D.E.
        • Adams M.D.
        • Orr C.M.D.
        • Schelling D.K.
        • Eiben R.M.
        • Kerr D.S.
        • et al.
        Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2.
        Am J Hum Genet. 2009; 84: 44-51
        • Shinohara M.
        • Saitoh M.
        • Nishizawa D.
        • Ikeda K.
        • Hirose S.
        • Takanashi J.
        • et al.
        ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus.
        Neurology. 2013; 80: 1571-1576
        • Yamazaki S.
        • Ikeno K.
        • Abe T.
        • Tohyama J.
        • Adachi Y.
        Hemiconvulsion-hemiplegia-epilepsy syndrome associated with CACNA1A S218L mutation.
        Pediatr Neurol. 2011; 45: 193-196
        • Belal H.
        • Nakashima M.
        • Matsumoto H.
        • Yokochi K.
        • Taniguchi-Ikeda M.
        • Aoto K.
        • et al.
        De novo variants in RHOBTB2, an atypical Rho GTPase gene, cause epileptic encephalopathy.
        Hum Mutat. 2018; 39: 1070-1075
        • Shimada S.
        • Oguni H.
        • Otani Y.
        • Nishikawa A.
        • Ito S.
        • Eto K.
        • et al.
        An episode of acute encephalopathy with biphasic seizures and late reduced diffusion followed by hemiplegia and intractable epilepsy observed in a patient with a novel frameshift mutation in HNRNPU.
        Brain Dev. 2018; 40: 813-818
        • Kurahashi H.
        • Azuma Y.
        • Akio M.
        • Okuno T.
        • Nakahara E.
        • Imamura T.
        • et al.
        MYRF is associated with encephalopathy with reversible myelin vacuolization.
        Ann Neurol. 2017; : 98-106
        • Takemaru M.
        • Shimoe Y.
        • Sato K.
        • Hashiguchi A.
        • Takashima H.
        • Kuriyama M.
        Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with heterozygote mutation of GJB1 gene: case report of a female patient (in Japanese).
        Rinsho Shinkeigaku (Tokyo). 2018; 58: 302-307
        • Sakauchi M.
        • Oguni H.
        • Kato I.
        • Osawa M.
        • Hirose S.
        • Kaneko S.
        • et al.
        Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome.
        Epilepsia. 2011; 52: 1144-1149
        • Okumura A.
        • Uematsu M.
        • Imataka G.
        • Tanaka M.
        • Okanishi T.
        • Kubota T.
        • et al.
        Acute encephalopathy in children with Dravet syndrome.
        Epilepsia. 2012; 53: 79-86
        • Ohmori I.
        • Ouchida M.
        • Miki T.
        • Mimaki N.
        • Kiyonaka S.
        • Nishiki T.
        • et al.
        A CACNB4 mutation shows that altered Cav2.1 function may be a genetic modifier of severe myoclonic epilepsy in infancy.
        Neurobiol Dis. 2008; 32: 349-354
        • Sakakibara T.
        • Nakagawa E.
        • Saito Y.
        • Sakuma H.
        • Komaki H.
        • Sugai K.
        • et al.
        Hemiconvulsion-hemiplegia syndrome in a patient with severe myoclonic epilepsy in infancy.
        Epilepsia. 2009; 50: 2158-2162
        • Takayanagi M.
        • Haginoya K.
        • Umehara N.
        • Kitamura T.
        • Numata Y.
        • Wakusawa K.
        • et al.
        Acute encephalopathy with a truncation mutation in the SCN1A gene: a case report.
        Epilepsia. 2010; 51: 1886-1888
        • Kobayashi K.
        • Ouchida M.
        • Okumura A.
        • Maegaki Y.
        • Nishiyama I.
        • Matsui H.
        • et al.
        Genetic seizure susceptibility underlying acute encephalopathies in childhood.
        Epilepsy Res. 2010; 91: 143-152
        • Saitoh M.
        • Shinohara M.
        • Hoshino H.
        • Kubota M.
        • Amemiya K.
        • Takanashi J.L.
        • et al.
        Mutations of the SCN1A gene in acute encephalopathy.
        Epilepsia. 2012; 53: 558-564
        • Saitoh M.
        • Ishii A.
        • Ihara Y.
        • Hoshino A.
        • Terashima H.
        • Kubota M.
        • et al.
        Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.
        Epilepsy Res. 2015; 117: 1-6
        • Kobayashi K.
        • Ohzono H.
        • Shinohara M.
        • Saitoh M.
        • Ohmori I.
        • Ohtsuka Y.
        • et al.
        Acute encephalopathy with a novel point mutation in the SCN2A gene.
        Epilepsy Res. 2012; 102: 109-112
        • Corti S.
        • Bordoni A.
        • Ronchi D.
        • Musumeci O.
        • Aguennouz M.
        • Toscano A.
        • et al.
        Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
        J Neurol Sci. 2008; 266: 97-103
        • Omata T.
        • Fujii K.
        • Takanashi J.I.
        • Murayama K.
        • Takayanagi M.
        • Muta K.
        • et al.
        Drugs indicated for mitochondrial dysfunction as treatments for acute encephalopathy with onset of febrile convulsive status epileptics.
        J Neurol Sci. 2016; 360: 57-60